Belief Biomed

Belief Biomed, established in 2016, is founded by Dr. Xiao, who has over 30-year experiences in gene therapy industry. The company is the developer and manufacturer of Adeno-Associated Virus (AAV) gene therapies for underserved patient populations with rare and generally untreatable genetic disorders, including Hemophilia B, Hemophilia A and mucopolysaccharidosis (MPS). The company owns various types of AAV capsids and gene vectors and  has built up world-leading mass production cell line of AAV.